Literature DB >> 6116902

Superiority of partial ileal bypass over cholestyramine reducing cholesterol in familial hypercholesterolaemia.

F A Spengel, A Jadhav, R G Duffield, C B Wood, G R Thompson.   

Abstract

Low density lipoprotein (LDL) turnover studies were conducted on three occasions in each of six patients with heterozygous familial hypercholesterolaemia (FH)-on diet, after 1 month on cholestyramine 16 g/day, and 2 months after partial ileal bypass. Partial ileal bypass lowered total and LDL cholesterol levels and increased the fractional catabolic rate of LDL to a greater extent than did cholestyramine; this difference presumably reflects the greater increase in bile acid excretion induced by the surgical procedure. Studies in two other heterozygotes showed that partial ileal bypass specifically enhanced receptor-mediated catabolism of LDL. The findings support the concept that therapeutic stimulation of bile acid synthesis increases the rate of receptor-mediated uptake and degradation of LDL by the liver.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6116902     DOI: 10.1016/s0140-6736(81)90183-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  13 in total

Review 1.  An overview of lipid-lowering drugs.

Authors:  D R Illingworth
Journal:  Drugs       Date:  1988       Impact factor: 9.546

2.  Partial ileal bypass for hypercholesterolemia. 20- to 26-year follow-up of the first 57 consecutive cases.

Authors:  H Buchwald; D K Stoller; C T Campos; J P Matts; R L Varco
Journal:  Ann Surg       Date:  1990-09       Impact factor: 12.969

3.  Familial hypercholesterolaemia commonly presents with Achilles tenosynovitis.

Authors:  D Beeharry; B Coupe; E W Benbow; J Morgan; S Kwok; V Charlton-Menys; M France; P N Durrington
Journal:  Ann Rheum Dis       Date:  2005-09-21       Impact factor: 19.103

4.  Fat absorption and metabolism.

Authors:  G Thompson
Journal:  Gastroenterol Jpn       Date:  1984-06

5.  Partial ileal bypass in the treatment of familial hypercholesterolemia.

Authors:  D Kelly; D Lane; G Gearly; P Quigley; G Neale; D G Weir
Journal:  Ir J Med Sci       Date:  1982-11       Impact factor: 1.568

Review 6.  Pathophysiology of human lipoprotein receptors: clinical consequences of a cellular defect.

Authors:  J Shepherd; C J Packard
Journal:  J Clin Pathol       Date:  1984-01       Impact factor: 3.411

7.  Difference in saturable binding of low density lipoprotein to liver membranes from normocholesterolemic subjects and patients with heterozygous familial hypercholesterolemia.

Authors:  K Harders-Spengel; C B Wood; G R Thompson; N B Myant; A K Soutar
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

Review 8.  Receptor-mediated low-density lipoprotein catabolism.

Authors:  F A Spengel; G R Thompson
Journal:  Klin Wochenschr       Date:  1982-04-01

9.  Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia.

Authors:  D R Illingworth; G J Sexton
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

10.  Hyperlipidaemia and premature coronary artery disease associated with sex-change in a female.

Authors:  C K ffrench-Constant; F A Spengel; G R Thompson
Journal:  Postgrad Med J       Date:  1985-01       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.